Indeed, circadian clocks also modulate a variety of cancer-related genes, including genes that control cell-cycle progression (e.g., c-Myc, cyclin D1, cyclin A, p53, and Mdm2), differentiation, DNA repair, and apoptosis (e.g., caspases) [88, 89]. This evidence concerns the gene CCND1 and cancer.